These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 11276003

  • 1. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
    Niki T, Iba S, Yamada T, Matsuno Y, Enholm B, Hirohashi S.
    J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K, Mandelin J, Partanen T, Jussila L, Li TF, Ristimaki A, Alitalo K, Konttinen YT.
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL, Veikkola T, Valtola R, Weiss SW.
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N.
    Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.
    Kim HS, Park YH, Lee J, Ahn JS, Kim J, Shim YM, Kim JH, Park K, Han J, Ahn MJ.
    Cancer; 2010 Feb 01; 116(3):676-85. PubMed ID: 20052735
    [Abstract] [Full Text] [Related]

  • 6. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 7. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.
    Witte D, Thomas A, Ali N, Carlson N, Younes M.
    Anticancer Res; 2002 Oct 15; 22(3):1463-6. PubMed ID: 12168824
    [Abstract] [Full Text] [Related]

  • 8. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
    Clarijs R, Schalkwijk L, Hofmann UB, Ruiter DJ, de Waal RM.
    Cancer Res; 2002 Dec 01; 62(23):7059-65. PubMed ID: 12460927
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
    Tian X, Song S, Wu J, Meng L, Dong Z, Shou C.
    Biochem Biophys Res Commun; 2001 Aug 24; 286(3):505-12. PubMed ID: 11511087
    [Abstract] [Full Text] [Related]

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 24; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 12. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D, Ciocci L, Cicerone E, Rossi C, Tiboni F, Ferrauti P, Gallo A, Baroni CD.
    J Pathol; 2001 Sep 15; 195(2):197-208. PubMed ID: 11592099
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiogenesis of lung cancer utilizes existing blood vessels rather than developing new vessels using signals from carcinogenesis.
    Uramoto H, Yamada S, Tanaka F.
    Anticancer Res; 2013 May 15; 33(5):1913-6. PubMed ID: 23645738
    [Abstract] [Full Text] [Related]

  • 17. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS, Kaneko M, Amatya VJ, Takeshima Y, Arihiro K, Inai K.
    Pathol Int; 2006 May 15; 56(5):256-61. PubMed ID: 16669874
    [Abstract] [Full Text] [Related]

  • 18. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H.
    Ai Zheng; 2005 Sep 15; 24(9):1132-5. PubMed ID: 16159440
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Höcker M.
    J Clin Oncol; 2006 Jan 10; 24(2):228-40. PubMed ID: 16344322
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M.
    Lung Cancer; 2007 Nov 10; 58(2):205-13. PubMed ID: 17686546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.